Baidu
map
INTERACT CARDIOV TH 润色咨询

Interactive Cardiovascular and Thoracic Surgery

出版年份：暂无数据 年文章数：243 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：4.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=575754, encodeId=83255e575427, content=您好，请问见刊一般是多久，从文章被接收后<span class="quote">Rivers Lee 2015-11-30 15:50:00 发表:<br>我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。</span>, beContent=Rivers Lee 2015-11-30 15:50:00 发表: 我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epvdHpdxRaj1DP03fZt2z4Fz3MPQiabzmDIV2ZndjibvXltDhDnUdPLz9FFsibPlySY2mSuiaIewjySNw/0, createdBy=8d392190865, createdName=pzxf瓶子, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958413, encodeId=12b1958413fc, content=投稿命中率:50.0<br>经验分享：胸心外科方向，投EJCTS后要求转ICVTS。审稿人认真，严格，还有统计学家审~<br>修改后顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852e5482102, createdName=ms3000001871855155, createdTime=Mon Apr 19 16:48:51 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585315, encodeId=ae165853158f, content=Title：Effects of antibiotic uutilization on children with Kawasaki disease：a retrospective study<span class="quote">徐志鹏 2020-02-25 发表::<br>川崎病的文章收吗？</span><span class="quote">徐志鹏 2020-02-25 00:00:00 发表:<br>川崎病的文章收吗？</span>, beContent=徐志鹏 2020-02-25 发表:: 川崎病的文章收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585314, encodeId=a979585314b6, content=川崎病的文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568637, encodeId=804e56863e94, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投稿：2018.12.16号 一审：2019.2.11，大修 返修：2月26号 二审：3月14号，大修 返修：3月18号 接受：3月25号 食管癌临床方向，前前后后4个月，杂志虽然分低但一点都不水，一审4个reviewer，50个问题，其中一个还是统计师，问题很专业，专家们基本一眼就找到了文章的痛处，统计师的问题最难搞。二审回10个问题，返修后没几天接受了。整体下来文章提升挺多，投这个稿学了蛮多东西的。感觉这个杂志创新性要求不高但对专业性和统计要求都蛮高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f02410532, createdName=fan2yin_29929336, createdTime=Tue Mar 26 00:00:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558631, encodeId=02d55586310c, content=一般两个月多可以出结果吗?<span class="quote">张雷长海血管 2018-05-25 20:07:00 发表:<br>虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投</span>, beContent=张雷长海血管 2018-05-25 20:07:00 发表: 虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOibia2eE9MMYeZNicS5kYcvN924pPztGGUVJDhMqIqu2MRQIGiatibxyWXeXI4Ll88AF3iafksh5jRh5w/132, createdBy=72172392205, createdName=超的世界, createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556441, encodeId=06b355644198, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=043d1742812, createdName=张雷长海血管, createdTime=Fri May 25 20:07:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554324, encodeId=6cd055432450, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：反反复复小修几个小问题，每次都要送外审半个月到一个月。EJCTS/ICVTS系列的杂志可以说越来越严了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Fri Mar 30 09:32:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552858, encodeId=cf6e552858c2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：先投了《欧洲心胸外科学》被推荐到这个杂志，在《欧洲心胸外科学》上一路坎坷，在这里一帆风顺。不过文章终究是发表了，也算是了却了学生生涯的一桩心事。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67862087505, createdName=Dr.Fengye, createdTime=Fri Feb 23 00:25:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542331, encodeId=6c4854233150, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2019-09-03 pzxf瓶子

    您好，请问见刊一般是多久，从文章被接收后Rivers Lee 2015-11-30 15:50:00 发表:
    我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。

    Rivers Lee 2015-11-30 15:50:00 发表: 我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=575754, encodeId=83255e575427, content=您好，请问见刊一般是多久，从文章被接收后<span class="quote">Rivers Lee 2015-11-30 15:50:00 发表:<br>我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。</span>, beContent=Rivers Lee 2015-11-30 15:50:00 发表: 我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epvdHpdxRaj1DP03fZt2z4Fz3MPQiabzmDIV2ZndjibvXltDhDnUdPLz9FFsibPlySY2mSuiaIewjySNw/0, createdBy=8d392190865, createdName=pzxf瓶子, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958413, encodeId=12b1958413fc, content=投稿命中率:50.0<br>经验分享：胸心外科方向，投EJCTS后要求转ICVTS。审稿人认真，严格，还有统计学家审~<br>修改后顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852e5482102, createdName=ms3000001871855155, createdTime=Mon Apr 19 16:48:51 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585315, encodeId=ae165853158f, content=Title：Effects of antibiotic uutilization on children with Kawasaki disease：a retrospective study<span class="quote">徐志鹏 2020-02-25 发表::<br>川崎病的文章收吗？</span><span class="quote">徐志鹏 2020-02-25 00:00:00 发表:<br>川崎病的文章收吗？</span>, beContent=徐志鹏 2020-02-25 发表:: 川崎病的文章收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585314, encodeId=a979585314b6, content=川崎病的文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568637, encodeId=804e56863e94, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投稿：2018.12.16号 一审：2019.2.11，大修 返修：2月26号 二审：3月14号，大修 返修：3月18号 接受：3月25号 食管癌临床方向，前前后后4个月，杂志虽然分低但一点都不水，一审4个reviewer，50个问题，其中一个还是统计师，问题很专业，专家们基本一眼就找到了文章的痛处，统计师的问题最难搞。二审回10个问题，返修后没几天接受了。整体下来文章提升挺多，投这个稿学了蛮多东西的。感觉这个杂志创新性要求不高但对专业性和统计要求都蛮高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f02410532, createdName=fan2yin_29929336, createdTime=Tue Mar 26 00:00:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558631, encodeId=02d55586310c, content=一般两个月多可以出结果吗?<span class="quote">张雷长海血管 2018-05-25 20:07:00 发表:<br>虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投</span>, beContent=张雷长海血管 2018-05-25 20:07:00 发表: 虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOibia2eE9MMYeZNicS5kYcvN924pPztGGUVJDhMqIqu2MRQIGiatibxyWXeXI4Ll88AF3iafksh5jRh5w/132, createdBy=72172392205, createdName=超的世界, createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556441, encodeId=06b355644198, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=043d1742812, createdName=张雷长海血管, createdTime=Fri May 25 20:07:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554324, encodeId=6cd055432450, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：反反复复小修几个小问题，每次都要送外审半个月到一个月。EJCTS/ICVTS系列的杂志可以说越来越严了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Fri Mar 30 09:32:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552858, encodeId=cf6e552858c2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：先投了《欧洲心胸外科学》被推荐到这个杂志，在《欧洲心胸外科学》上一路坎坷，在这里一帆风顺。不过文章终究是发表了，也算是了却了学生生涯的一桩心事。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67862087505, createdName=Dr.Fengye, createdTime=Fri Feb 23 00:25:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542331, encodeId=6c4854233150, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2021-04-19 ms3000001871855155

    投稿命中率:50.0
    经验分享：胸心外科方向，投EJCTS后要求转ICVTS。审稿人认真，严格，还有统计学家审~
    修改后顺利接受。

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=575754, encodeId=83255e575427, content=您好，请问见刊一般是多久，从文章被接收后<span class="quote">Rivers Lee 2015-11-30 15:50:00 发表:<br>我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。</span>, beContent=Rivers Lee 2015-11-30 15:50:00 发表: 我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epvdHpdxRaj1DP03fZt2z4Fz3MPQiabzmDIV2ZndjibvXltDhDnUdPLz9FFsibPlySY2mSuiaIewjySNw/0, createdBy=8d392190865, createdName=pzxf瓶子, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958413, encodeId=12b1958413fc, content=投稿命中率:50.0<br>经验分享：胸心外科方向，投EJCTS后要求转ICVTS。审稿人认真，严格，还有统计学家审~<br>修改后顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852e5482102, createdName=ms3000001871855155, createdTime=Mon Apr 19 16:48:51 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585315, encodeId=ae165853158f, content=Title：Effects of antibiotic uutilization on children with Kawasaki disease：a retrospective study<span class="quote">徐志鹏 2020-02-25 发表::<br>川崎病的文章收吗？</span><span class="quote">徐志鹏 2020-02-25 00:00:00 发表:<br>川崎病的文章收吗？</span>, beContent=徐志鹏 2020-02-25 发表:: 川崎病的文章收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585314, encodeId=a979585314b6, content=川崎病的文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568637, encodeId=804e56863e94, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投稿：2018.12.16号 一审：2019.2.11，大修 返修：2月26号 二审：3月14号，大修 返修：3月18号 接受：3月25号 食管癌临床方向，前前后后4个月，杂志虽然分低但一点都不水，一审4个reviewer，50个问题，其中一个还是统计师，问题很专业，专家们基本一眼就找到了文章的痛处，统计师的问题最难搞。二审回10个问题，返修后没几天接受了。整体下来文章提升挺多，投这个稿学了蛮多东西的。感觉这个杂志创新性要求不高但对专业性和统计要求都蛮高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f02410532, createdName=fan2yin_29929336, createdTime=Tue Mar 26 00:00:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558631, encodeId=02d55586310c, content=一般两个月多可以出结果吗?<span class="quote">张雷长海血管 2018-05-25 20:07:00 发表:<br>虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投</span>, beContent=张雷长海血管 2018-05-25 20:07:00 发表: 虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOibia2eE9MMYeZNicS5kYcvN924pPztGGUVJDhMqIqu2MRQIGiatibxyWXeXI4Ll88AF3iafksh5jRh5w/132, createdBy=72172392205, createdName=超的世界, createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556441, encodeId=06b355644198, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=043d1742812, createdName=张雷长海血管, createdTime=Fri May 25 20:07:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554324, encodeId=6cd055432450, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：反反复复小修几个小问题，每次都要送外审半个月到一个月。EJCTS/ICVTS系列的杂志可以说越来越严了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Fri Mar 30 09:32:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552858, encodeId=cf6e552858c2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：先投了《欧洲心胸外科学》被推荐到这个杂志，在《欧洲心胸外科学》上一路坎坷，在这里一帆风顺。不过文章终究是发表了，也算是了却了学生生涯的一桩心事。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67862087505, createdName=Dr.Fengye, createdTime=Fri Feb 23 00:25:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542331, encodeId=6c4854233150, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2020-02-25 徐志鹏

    Title：Effects of antibiotic uutilization on children with Kawasaki disease：a retrospective study徐志鹏 2020-02-25 发表::
    川崎病的文章收吗？    徐志鹏 2020-02-25 00:00:00 发表:
    川崎病的文章收吗？

    徐志鹏 2020-02-25 发表:: 川崎病的文章收吗？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=575754, encodeId=83255e575427, content=您好，请问见刊一般是多久，从文章被接收后<span class="quote">Rivers Lee 2015-11-30 15:50:00 发表:<br>我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。</span>, beContent=Rivers Lee 2015-11-30 15:50:00 发表: 我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epvdHpdxRaj1DP03fZt2z4Fz3MPQiabzmDIV2ZndjibvXltDhDnUdPLz9FFsibPlySY2mSuiaIewjySNw/0, createdBy=8d392190865, createdName=pzxf瓶子, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958413, encodeId=12b1958413fc, content=投稿命中率:50.0<br>经验分享：胸心外科方向，投EJCTS后要求转ICVTS。审稿人认真，严格，还有统计学家审~<br>修改后顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852e5482102, createdName=ms3000001871855155, createdTime=Mon Apr 19 16:48:51 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585315, encodeId=ae165853158f, content=Title：Effects of antibiotic uutilization on children with Kawasaki disease：a retrospective study<span class="quote">徐志鹏 2020-02-25 发表::<br>川崎病的文章收吗？</span><span class="quote">徐志鹏 2020-02-25 00:00:00 发表:<br>川崎病的文章收吗？</span>, beContent=徐志鹏 2020-02-25 发表:: 川崎病的文章收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585314, encodeId=a979585314b6, content=川崎病的文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568637, encodeId=804e56863e94, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投稿：2018.12.16号 一审：2019.2.11，大修 返修：2月26号 二审：3月14号，大修 返修：3月18号 接受：3月25号 食管癌临床方向，前前后后4个月，杂志虽然分低但一点都不水，一审4个reviewer，50个问题，其中一个还是统计师，问题很专业，专家们基本一眼就找到了文章的痛处，统计师的问题最难搞。二审回10个问题，返修后没几天接受了。整体下来文章提升挺多，投这个稿学了蛮多东西的。感觉这个杂志创新性要求不高但对专业性和统计要求都蛮高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f02410532, createdName=fan2yin_29929336, createdTime=Tue Mar 26 00:00:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558631, encodeId=02d55586310c, content=一般两个月多可以出结果吗?<span class="quote">张雷长海血管 2018-05-25 20:07:00 发表:<br>虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投</span>, beContent=张雷长海血管 2018-05-25 20:07:00 发表: 虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOibia2eE9MMYeZNicS5kYcvN924pPztGGUVJDhMqIqu2MRQIGiatibxyWXeXI4Ll88AF3iafksh5jRh5w/132, createdBy=72172392205, createdName=超的世界, createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556441, encodeId=06b355644198, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=043d1742812, createdName=张雷长海血管, createdTime=Fri May 25 20:07:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554324, encodeId=6cd055432450, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：反反复复小修几个小问题，每次都要送外审半个月到一个月。EJCTS/ICVTS系列的杂志可以说越来越严了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Fri Mar 30 09:32:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552858, encodeId=cf6e552858c2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：先投了《欧洲心胸外科学》被推荐到这个杂志，在《欧洲心胸外科学》上一路坎坷，在这里一帆风顺。不过文章终究是发表了，也算是了却了学生生涯的一桩心事。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67862087505, createdName=Dr.Fengye, createdTime=Fri Feb 23 00:25:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542331, encodeId=6c4854233150, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2020-02-25 徐志鹏

    川崎病的文章收吗？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=575754, encodeId=83255e575427, content=您好，请问见刊一般是多久，从文章被接收后<span class="quote">Rivers Lee 2015-11-30 15:50:00 发表:<br>我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。</span>, beContent=Rivers Lee 2015-11-30 15:50:00 发表: 我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epvdHpdxRaj1DP03fZt2z4Fz3MPQiabzmDIV2ZndjibvXltDhDnUdPLz9FFsibPlySY2mSuiaIewjySNw/0, createdBy=8d392190865, createdName=pzxf瓶子, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958413, encodeId=12b1958413fc, content=投稿命中率:50.0<br>经验分享：胸心外科方向，投EJCTS后要求转ICVTS。审稿人认真，严格，还有统计学家审~<br>修改后顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852e5482102, createdName=ms3000001871855155, createdTime=Mon Apr 19 16:48:51 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585315, encodeId=ae165853158f, content=Title：Effects of antibiotic uutilization on children with Kawasaki disease：a retrospective study<span class="quote">徐志鹏 2020-02-25 发表::<br>川崎病的文章收吗？</span><span class="quote">徐志鹏 2020-02-25 00:00:00 发表:<br>川崎病的文章收吗？</span>, beContent=徐志鹏 2020-02-25 发表:: 川崎病的文章收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585314, encodeId=a979585314b6, content=川崎病的文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568637, encodeId=804e56863e94, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投稿：2018.12.16号 一审：2019.2.11，大修 返修：2月26号 二审：3月14号，大修 返修：3月18号 接受：3月25号 食管癌临床方向，前前后后4个月，杂志虽然分低但一点都不水，一审4个reviewer，50个问题，其中一个还是统计师，问题很专业，专家们基本一眼就找到了文章的痛处，统计师的问题最难搞。二审回10个问题，返修后没几天接受了。整体下来文章提升挺多，投这个稿学了蛮多东西的。感觉这个杂志创新性要求不高但对专业性和统计要求都蛮高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f02410532, createdName=fan2yin_29929336, createdTime=Tue Mar 26 00:00:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558631, encodeId=02d55586310c, content=一般两个月多可以出结果吗?<span class="quote">张雷长海血管 2018-05-25 20:07:00 发表:<br>虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投</span>, beContent=张雷长海血管 2018-05-25 20:07:00 发表: 虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOibia2eE9MMYeZNicS5kYcvN924pPztGGUVJDhMqIqu2MRQIGiatibxyWXeXI4Ll88AF3iafksh5jRh5w/132, createdBy=72172392205, createdName=超的世界, createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556441, encodeId=06b355644198, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=043d1742812, createdName=张雷长海血管, createdTime=Fri May 25 20:07:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554324, encodeId=6cd055432450, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：反反复复小修几个小问题，每次都要送外审半个月到一个月。EJCTS/ICVTS系列的杂志可以说越来越严了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Fri Mar 30 09:32:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552858, encodeId=cf6e552858c2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：先投了《欧洲心胸外科学》被推荐到这个杂志，在《欧洲心胸外科学》上一路坎坷，在这里一帆风顺。不过文章终究是发表了，也算是了却了学生生涯的一桩心事。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67862087505, createdName=Dr.Fengye, createdTime=Fri Feb 23 00:25:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542331, encodeId=6c4854233150, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2019-03-26 fan2yin_29929336

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：投稿：2018.12.16号 一审：2019.2.11，大修 返修：2月26号 二审：3月14号，大修 返修：3月18号 接受：3月25号 食管癌临床方向，前前后后4个月，杂志虽然分低但一点都不水，一审4个reviewer，50个问题，其中一个还是统计师，问题很专业，专家们基本一眼就找到了文章的痛处，统计师的问题最难搞。二审回10个问题，返修后没几天接受了。整体下来文章提升挺多，投这个稿学了蛮多东西的。感觉这个杂志创新性要求不高但对专业性和统计要求都蛮高的

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=575754, encodeId=83255e575427, content=您好，请问见刊一般是多久，从文章被接收后<span class="quote">Rivers Lee 2015-11-30 15:50:00 发表:<br>我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。</span>, beContent=Rivers Lee 2015-11-30 15:50:00 发表: 我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epvdHpdxRaj1DP03fZt2z4Fz3MPQiabzmDIV2ZndjibvXltDhDnUdPLz9FFsibPlySY2mSuiaIewjySNw/0, createdBy=8d392190865, createdName=pzxf瓶子, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958413, encodeId=12b1958413fc, content=投稿命中率:50.0<br>经验分享：胸心外科方向，投EJCTS后要求转ICVTS。审稿人认真，严格，还有统计学家审~<br>修改后顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852e5482102, createdName=ms3000001871855155, createdTime=Mon Apr 19 16:48:51 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585315, encodeId=ae165853158f, content=Title：Effects of antibiotic uutilization on children with Kawasaki disease：a retrospective study<span class="quote">徐志鹏 2020-02-25 发表::<br>川崎病的文章收吗？</span><span class="quote">徐志鹏 2020-02-25 00:00:00 发表:<br>川崎病的文章收吗？</span>, beContent=徐志鹏 2020-02-25 发表:: 川崎病的文章收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585314, encodeId=a979585314b6, content=川崎病的文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568637, encodeId=804e56863e94, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投稿：2018.12.16号 一审：2019.2.11，大修 返修：2月26号 二审：3月14号，大修 返修：3月18号 接受：3月25号 食管癌临床方向，前前后后4个月，杂志虽然分低但一点都不水，一审4个reviewer，50个问题，其中一个还是统计师，问题很专业，专家们基本一眼就找到了文章的痛处，统计师的问题最难搞。二审回10个问题，返修后没几天接受了。整体下来文章提升挺多，投这个稿学了蛮多东西的。感觉这个杂志创新性要求不高但对专业性和统计要求都蛮高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f02410532, createdName=fan2yin_29929336, createdTime=Tue Mar 26 00:00:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558631, encodeId=02d55586310c, content=一般两个月多可以出结果吗?<span class="quote">张雷长海血管 2018-05-25 20:07:00 发表:<br>虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投</span>, beContent=张雷长海血管 2018-05-25 20:07:00 发表: 虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOibia2eE9MMYeZNicS5kYcvN924pPztGGUVJDhMqIqu2MRQIGiatibxyWXeXI4Ll88AF3iafksh5jRh5w/132, createdBy=72172392205, createdName=超的世界, createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556441, encodeId=06b355644198, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=043d1742812, createdName=张雷长海血管, createdTime=Fri May 25 20:07:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554324, encodeId=6cd055432450, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：反反复复小修几个小问题，每次都要送外审半个月到一个月。EJCTS/ICVTS系列的杂志可以说越来越严了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Fri Mar 30 09:32:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552858, encodeId=cf6e552858c2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：先投了《欧洲心胸外科学》被推荐到这个杂志，在《欧洲心胸外科学》上一路坎坷，在这里一帆风顺。不过文章终究是发表了，也算是了却了学生生涯的一桩心事。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67862087505, createdName=Dr.Fengye, createdTime=Fri Feb 23 00:25:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542331, encodeId=6c4854233150, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2018-06-29 超的世界

    一般两个月多可以出结果吗?张雷长海血管 2018-05-25 20:07:00 发表:
    虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投

    张雷长海血管 2018-05-25 20:07:00 发表: 虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=575754, encodeId=83255e575427, content=您好，请问见刊一般是多久，从文章被接收后<span class="quote">Rivers Lee 2015-11-30 15:50:00 发表:<br>我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。</span>, beContent=Rivers Lee 2015-11-30 15:50:00 发表: 我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epvdHpdxRaj1DP03fZt2z4Fz3MPQiabzmDIV2ZndjibvXltDhDnUdPLz9FFsibPlySY2mSuiaIewjySNw/0, createdBy=8d392190865, createdName=pzxf瓶子, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958413, encodeId=12b1958413fc, content=投稿命中率:50.0<br>经验分享：胸心外科方向，投EJCTS后要求转ICVTS。审稿人认真，严格，还有统计学家审~<br>修改后顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852e5482102, createdName=ms3000001871855155, createdTime=Mon Apr 19 16:48:51 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585315, encodeId=ae165853158f, content=Title：Effects of antibiotic uutilization on children with Kawasaki disease：a retrospective study<span class="quote">徐志鹏 2020-02-25 发表::<br>川崎病的文章收吗？</span><span class="quote">徐志鹏 2020-02-25 00:00:00 发表:<br>川崎病的文章收吗？</span>, beContent=徐志鹏 2020-02-25 发表:: 川崎病的文章收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585314, encodeId=a979585314b6, content=川崎病的文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568637, encodeId=804e56863e94, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投稿：2018.12.16号 一审：2019.2.11，大修 返修：2月26号 二审：3月14号，大修 返修：3月18号 接受：3月25号 食管癌临床方向，前前后后4个月，杂志虽然分低但一点都不水，一审4个reviewer，50个问题，其中一个还是统计师，问题很专业，专家们基本一眼就找到了文章的痛处，统计师的问题最难搞。二审回10个问题，返修后没几天接受了。整体下来文章提升挺多，投这个稿学了蛮多东西的。感觉这个杂志创新性要求不高但对专业性和统计要求都蛮高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f02410532, createdName=fan2yin_29929336, createdTime=Tue Mar 26 00:00:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558631, encodeId=02d55586310c, content=一般两个月多可以出结果吗?<span class="quote">张雷长海血管 2018-05-25 20:07:00 发表:<br>虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投</span>, beContent=张雷长海血管 2018-05-25 20:07:00 发表: 虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOibia2eE9MMYeZNicS5kYcvN924pPztGGUVJDhMqIqu2MRQIGiatibxyWXeXI4Ll88AF3iafksh5jRh5w/132, createdBy=72172392205, createdName=超的世界, createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556441, encodeId=06b355644198, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=043d1742812, createdName=张雷长海血管, createdTime=Fri May 25 20:07:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554324, encodeId=6cd055432450, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：反反复复小修几个小问题，每次都要送外审半个月到一个月。EJCTS/ICVTS系列的杂志可以说越来越严了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Fri Mar 30 09:32:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552858, encodeId=cf6e552858c2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：先投了《欧洲心胸外科学》被推荐到这个杂志，在《欧洲心胸外科学》上一路坎坷，在这里一帆风顺。不过文章终究是发表了，也算是了却了学生生涯的一桩心事。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67862087505, createdName=Dr.Fengye, createdTime=Fri Feb 23 00:25:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542331, encodeId=6c4854233150, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2018-05-25 张雷长海血管

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=575754, encodeId=83255e575427, content=您好，请问见刊一般是多久，从文章被接收后<span class="quote">Rivers Lee 2015-11-30 15:50:00 发表:<br>我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。</span>, beContent=Rivers Lee 2015-11-30 15:50:00 发表: 我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epvdHpdxRaj1DP03fZt2z4Fz3MPQiabzmDIV2ZndjibvXltDhDnUdPLz9FFsibPlySY2mSuiaIewjySNw/0, createdBy=8d392190865, createdName=pzxf瓶子, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958413, encodeId=12b1958413fc, content=投稿命中率:50.0<br>经验分享：胸心外科方向，投EJCTS后要求转ICVTS。审稿人认真，严格，还有统计学家审~<br>修改后顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852e5482102, createdName=ms3000001871855155, createdTime=Mon Apr 19 16:48:51 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585315, encodeId=ae165853158f, content=Title：Effects of antibiotic uutilization on children with Kawasaki disease：a retrospective study<span class="quote">徐志鹏 2020-02-25 发表::<br>川崎病的文章收吗？</span><span class="quote">徐志鹏 2020-02-25 00:00:00 发表:<br>川崎病的文章收吗？</span>, beContent=徐志鹏 2020-02-25 发表:: 川崎病的文章收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585314, encodeId=a979585314b6, content=川崎病的文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568637, encodeId=804e56863e94, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投稿：2018.12.16号 一审：2019.2.11，大修 返修：2月26号 二审：3月14号，大修 返修：3月18号 接受：3月25号 食管癌临床方向，前前后后4个月，杂志虽然分低但一点都不水，一审4个reviewer，50个问题，其中一个还是统计师，问题很专业，专家们基本一眼就找到了文章的痛处，统计师的问题最难搞。二审回10个问题，返修后没几天接受了。整体下来文章提升挺多，投这个稿学了蛮多东西的。感觉这个杂志创新性要求不高但对专业性和统计要求都蛮高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f02410532, createdName=fan2yin_29929336, createdTime=Tue Mar 26 00:00:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558631, encodeId=02d55586310c, content=一般两个月多可以出结果吗?<span class="quote">张雷长海血管 2018-05-25 20:07:00 发表:<br>虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投</span>, beContent=张雷长海血管 2018-05-25 20:07:00 发表: 虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOibia2eE9MMYeZNicS5kYcvN924pPztGGUVJDhMqIqu2MRQIGiatibxyWXeXI4Ll88AF3iafksh5jRh5w/132, createdBy=72172392205, createdName=超的世界, createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556441, encodeId=06b355644198, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=043d1742812, createdName=张雷长海血管, createdTime=Fri May 25 20:07:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554324, encodeId=6cd055432450, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：反反复复小修几个小问题，每次都要送外审半个月到一个月。EJCTS/ICVTS系列的杂志可以说越来越严了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Fri Mar 30 09:32:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552858, encodeId=cf6e552858c2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：先投了《欧洲心胸外科学》被推荐到这个杂志，在《欧洲心胸外科学》上一路坎坷，在这里一帆风顺。不过文章终究是发表了，也算是了却了学生生涯的一桩心事。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67862087505, createdName=Dr.Fengye, createdTime=Fri Feb 23 00:25:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542331, encodeId=6c4854233150, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2018-03-30 Rivers Lee

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享：反反复复小修几个小问题，每次都要送外审半个月到一个月。EJCTS/ICVTS系列的杂志可以说越来越严了。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=575754, encodeId=83255e575427, content=您好，请问见刊一般是多久，从文章被接收后<span class="quote">Rivers Lee 2015-11-30 15:50:00 发表:<br>我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。</span>, beContent=Rivers Lee 2015-11-30 15:50:00 发表: 我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epvdHpdxRaj1DP03fZt2z4Fz3MPQiabzmDIV2ZndjibvXltDhDnUdPLz9FFsibPlySY2mSuiaIewjySNw/0, createdBy=8d392190865, createdName=pzxf瓶子, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958413, encodeId=12b1958413fc, content=投稿命中率:50.0<br>经验分享：胸心外科方向，投EJCTS后要求转ICVTS。审稿人认真，严格，还有统计学家审~<br>修改后顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852e5482102, createdName=ms3000001871855155, createdTime=Mon Apr 19 16:48:51 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585315, encodeId=ae165853158f, content=Title：Effects of antibiotic uutilization on children with Kawasaki disease：a retrospective study<span class="quote">徐志鹏 2020-02-25 发表::<br>川崎病的文章收吗？</span><span class="quote">徐志鹏 2020-02-25 00:00:00 发表:<br>川崎病的文章收吗？</span>, beContent=徐志鹏 2020-02-25 发表:: 川崎病的文章收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585314, encodeId=a979585314b6, content=川崎病的文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568637, encodeId=804e56863e94, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投稿：2018.12.16号 一审：2019.2.11，大修 返修：2月26号 二审：3月14号，大修 返修：3月18号 接受：3月25号 食管癌临床方向，前前后后4个月，杂志虽然分低但一点都不水，一审4个reviewer，50个问题，其中一个还是统计师，问题很专业，专家们基本一眼就找到了文章的痛处，统计师的问题最难搞。二审回10个问题，返修后没几天接受了。整体下来文章提升挺多，投这个稿学了蛮多东西的。感觉这个杂志创新性要求不高但对专业性和统计要求都蛮高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f02410532, createdName=fan2yin_29929336, createdTime=Tue Mar 26 00:00:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558631, encodeId=02d55586310c, content=一般两个月多可以出结果吗?<span class="quote">张雷长海血管 2018-05-25 20:07:00 发表:<br>虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投</span>, beContent=张雷长海血管 2018-05-25 20:07:00 发表: 虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOibia2eE9MMYeZNicS5kYcvN924pPztGGUVJDhMqIqu2MRQIGiatibxyWXeXI4Ll88AF3iafksh5jRh5w/132, createdBy=72172392205, createdName=超的世界, createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556441, encodeId=06b355644198, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=043d1742812, createdName=张雷长海血管, createdTime=Fri May 25 20:07:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554324, encodeId=6cd055432450, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：反反复复小修几个小问题，每次都要送外审半个月到一个月。EJCTS/ICVTS系列的杂志可以说越来越严了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Fri Mar 30 09:32:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552858, encodeId=cf6e552858c2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：先投了《欧洲心胸外科学》被推荐到这个杂志，在《欧洲心胸外科学》上一路坎坷，在这里一帆风顺。不过文章终究是发表了，也算是了却了学生生涯的一桩心事。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67862087505, createdName=Dr.Fengye, createdTime=Fri Feb 23 00:25:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542331, encodeId=6c4854233150, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2018-02-23 Dr.Fengye

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：先投了《欧洲心胸外科学》被推荐到这个杂志，在《欧洲心胸外科学》上一路坎坷，在这里一帆风顺。不过文章终究是发表了，也算是了却了学生生涯的一桩心事。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=575754, encodeId=83255e575427, content=您好，请问见刊一般是多久，从文章被接收后<span class="quote">Rivers Lee 2015-11-30 15:50:00 发表:<br>我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。</span>, beContent=Rivers Lee 2015-11-30 15:50:00 发表: 我中的第一篇sci文章就是投的这个杂志，感觉这个杂志虽然分数并不是很高，但是却比较严格。因为是EJCTS旗下的子刊，审稿人的问题很专业。8月份投的，审了1个月13天，给了小修，一个审稿人印象很好，另一个比较苛刻了，但最终还是中了。见刊也比较快。德国人的效率的确高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epvdHpdxRaj1DP03fZt2z4Fz3MPQiabzmDIV2ZndjibvXltDhDnUdPLz9FFsibPlySY2mSuiaIewjySNw/0, createdBy=8d392190865, createdName=pzxf瓶子, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958413, encodeId=12b1958413fc, content=投稿命中率:50.0<br>经验分享：胸心外科方向，投EJCTS后要求转ICVTS。审稿人认真，严格，还有统计学家审~<br>修改后顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852e5482102, createdName=ms3000001871855155, createdTime=Mon Apr 19 16:48:51 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585315, encodeId=ae165853158f, content=Title：Effects of antibiotic uutilization on children with Kawasaki disease：a retrospective study<span class="quote">徐志鹏 2020-02-25 发表::<br>川崎病的文章收吗？</span><span class="quote">徐志鹏 2020-02-25 00:00:00 发表:<br>川崎病的文章收吗？</span>, beContent=徐志鹏 2020-02-25 发表:: 川崎病的文章收吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585314, encodeId=a979585314b6, content=川崎病的文章收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTINlibS3MWGicN2WDqZJ6165B7eB4xMm9GrqnjK11DzibdicLX6T30aibfB9TvDzrPCGibyOj7REjlFQxxA/132, createdBy=10cf5286279, createdName=徐志鹏, createdTime=Tue Feb 25 00:00:00 CST 2020, time=2020-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568637, encodeId=804e56863e94, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：投稿：2018.12.16号 一审：2019.2.11，大修 返修：2月26号 二审：3月14号，大修 返修：3月18号 接受：3月25号 食管癌临床方向，前前后后4个月，杂志虽然分低但一点都不水，一审4个reviewer，50个问题，其中一个还是统计师，问题很专业，专家们基本一眼就找到了文章的痛处，统计师的问题最难搞。二审回10个问题，返修后没几天接受了。整体下来文章提升挺多，投这个稿学了蛮多东西的。感觉这个杂志创新性要求不高但对专业性和统计要求都蛮高的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f02410532, createdName=fan2yin_29929336, createdTime=Tue Mar 26 00:00:00 CST 2019, time=2019-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558631, encodeId=02d55586310c, content=一般两个月多可以出结果吗?<span class="quote">张雷长海血管 2018-05-25 20:07:00 发表:<br>虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投</span>, beContent=张雷长海血管 2018-05-25 20:07:00 发表: 虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOibia2eE9MMYeZNicS5kYcvN924pPztGGUVJDhMqIqu2MRQIGiatibxyWXeXI4Ll88AF3iafksh5jRh5w/132, createdBy=72172392205, createdName=超的世界, createdTime=Fri Jun 29 00:00:00 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556441, encodeId=06b355644198, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：虽然经常有被ejctv转过去的文章.但如果文章质量可以.也没必要一定转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=043d1742812, createdName=张雷长海血管, createdTime=Fri May 25 20:07:00 CST 2018, time=2018-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554324, encodeId=6cd055432450, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：反反复复小修几个小问题，每次都要送外审半个月到一个月。EJCTS/ICVTS系列的杂志可以说越来越严了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Fri Mar 30 09:32:00 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552858, encodeId=cf6e552858c2, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：先投了《欧洲心胸外科学》被推荐到这个杂志，在《欧洲心胸外科学》上一路坎坷，在这里一帆风顺。不过文章终究是发表了，也算是了却了学生生涯的一桩心事。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67862087505, createdName=Dr.Fengye, createdTime=Fri Feb 23 00:25:00 CST 2018, time=2018-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542331, encodeId=6c4854233150, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]
    2017-07-14 qiqi

    从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有

    0

共21条页码: 1/3页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map